GALIMI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.614
EU - Europa 1.137
AS - Asia 741
OC - Oceania 19
AF - Africa 8
SA - Sud America 5
Totale 4.524
Nazione #
US - Stati Uniti d'America 2.568
CN - Cina 473
IT - Italia 362
DE - Germania 146
IE - Irlanda 107
GB - Regno Unito 93
SE - Svezia 74
JP - Giappone 66
AT - Austria 50
FR - Francia 50
FI - Finlandia 45
UA - Ucraina 43
CA - Canada 39
IN - India 37
PL - Polonia 37
KR - Corea 31
HK - Hong Kong 24
SG - Singapore 24
NL - Olanda 23
VN - Vietnam 21
ES - Italia 19
AU - Australia 17
BE - Belgio 17
TW - Taiwan 17
TR - Turchia 13
CH - Svizzera 12
RU - Federazione Russa 12
IR - Iran 9
DK - Danimarca 8
RO - Romania 8
TH - Thailandia 8
CZ - Repubblica Ceca 6
NO - Norvegia 6
MX - Messico 5
GR - Grecia 4
UZ - Uzbekistan 4
CO - Colombia 3
EE - Estonia 3
HU - Ungheria 3
LK - Sri Lanka 3
ZA - Sudafrica 3
DM - Dominica 2
EG - Egitto 2
ID - Indonesia 2
IL - Israele 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 4.524
Città #
Ann Arbor 506
Chandler 283
Fairfield 261
Beijing 139
Ashburn 135
Seattle 118
Woodbridge 116
Houston 102
Dublin 93
Wilmington 88
Cambridge 87
Torino 83
Shanghai 67
Pisa 48
Vienna 48
Dearborn 41
Nyköping 36
Redwood City 35
Tokyo 30
Warsaw 30
Jacksonville 28
New York 28
Princeton 26
Villeurbanne 24
Medford 22
Milan 22
Guangzhou 20
San Diego 18
Taipei 16
Brussels 15
Manchester 15
Ottawa 15
Turin 15
Changsha 14
Fremont 14
Boston 13
Hangzhou 13
London 13
Los Angeles 13
Genoa 12
Dong Ket 11
Nanchang 11
Nanjing 11
Helsinki 10
Luni 10
Rome 10
Shenyang 10
Wuhan 10
Boardman 9
Seoul 9
Toronto 9
Amsterdam 8
Munich 8
Paris 8
Salt Lake City 8
Austin 7
Chengdu 7
Duncan 7
Zhengzhou 7
Buffalo 6
Central 6
Chicago 6
Chongqing 6
Eitensheim 6
Heidelberg 6
Kocaeli 6
Nashville 6
Pittsburgh 6
Shenzhen 6
Silver Spring 6
Singapore 6
Zurich 6
Bangkok 5
Barcelona 5
Bethesda 5
Birmingham 5
Changchun 5
Fuzhou 5
Gurgaon 5
Madison 5
Melbourne 5
Bologna 4
Brookline 4
Chatsworth 4
Columbus 4
Delhi 4
Düsseldorf 4
Falls Church 4
Galway 4
Hong Kong 4
Jinan 4
Norwalk 4
Regensburg 4
Saint Louis 4
Serra 4
Southend 4
Washington 4
Ankara 3
Bangalore 3
Bochum 3
Totale 3.068
Nome #
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 672
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 570
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 318
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 307
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 289
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 261
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3. 238
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 235
Only a subset of Met-activated pathways are required to sustain oncogene addiction 233
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 215
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 205
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 201
Inhibition of Src impairs the growth of met-addicted gastric tumors. 195
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 164
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 163
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 77
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 71
Signaling response to transient redox stress in human isolated T cells: Molecular sensor role of syk kinase and functional involvement of IL2 receptor and L-selectine 68
Met as a potential therapeutic target in basal-like breast cancer 67
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 64
Totale 4.613
Categoria #
all - tutte 8.856
article - articoli 0
book - libri 0
conference - conferenze 1.095
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019313 0 0 0 0 0 0 0 0 0 64 152 97
2019/2020706 71 27 35 102 55 87 80 57 67 49 42 34
2020/2021603 34 50 58 38 32 47 69 38 45 63 32 97
2021/20221.006 110 90 72 98 62 59 87 71 52 62 149 94
2022/2023736 73 77 31 78 52 149 41 64 70 16 44 41
2023/2024424 56 54 35 46 38 51 33 66 16 29 0 0
Totale 4.613